Kestra Private Wealth Services, LLC Cyma Bay Therapeutics, Inc. Transaction History

Kestra Private Wealth Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$3.23 - $4.6 $1.62 Million - $2.3 Million	-501,000 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$3.94 - $4.92 $1.97 Million - $2.46 Million	501,000 New	501,000 $2.18 Million
Q1 2021 May 11, 2021	SELL	$4.23 - $6.55 $1.7 Million - $2.63 Million	-401,000 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$5.73 - $9.03 $578,730 - $912,029	101,000 Added 33.67%	401,000 $2.36 Billion
Q3 2020 Nov 09, 2020	BUY	$3.32 - $7.24 $996,000 - $2.17 Million	300,000 New	300,000 $2.17 Million

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Kestra Private Wealth Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Private Wealth Services, LLC with notifications on news.